Not Tagged
Not Tagged
['dlbcl']
#ash22 teaches us (me at least) that ai methods can also be leveraged to predict response to car-t in r/r patients with dlbcl. considering also cost-related issues of these new therapies, judiciously assign patients is crucial!!! brava dr. margot jak! 
MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own